
Cannon Artes, a pioneer in engineering solutions, introduces groundbreaking water and wastewater treatment technologies tailored for the pharmaceutical sector, driving sustainability with over 20% of treated water suitable for reuse.
April 12, 2024
We proudly announce groundbreaking advancements in water and wastewater treatment technologies tailored specifically for the pharmaceutical market. With installations in over 80 countries, we treat more than 500 million cubic meters of water annually, and over 20% are suitable for reuse. The commitment to sustainability drives our efforts in developing innovative systems for water reuse and micro-pollutant removal, addressing environmental concerns within the sector.
The pharmaceutical industry is increasingly prioritizing environmental sustainability, driving major players to implement initiatives to minimize their environmental footprint. Our cutting-edge solutions enable pharmaceutical companies to reduce water consumption during production, recycle effluents, and enhance effluent quality through advanced technologies, resulting in significant reductions in pollutants discharged into the environment. With a dedicated R&D department, we offers unparalleled support to customers in identifying and implementing innovative solutions to address these critical challenges.
Leveraging advanced technologies such as proprietary membrane bioreactor EmbioArt® MBR and induced gas flotation technology FlotArt®, we deliver efficient and cost-effective solutions for organic pollutant and suspended solids removal, as well as the treatment of specific compounds such as APIs (Active Pharmaceutical Ingredients).
EmbioArt® MBR offers a revolutionary membrane biological treatment for organic matter and nitrogen removal from various wastewater streams, providing higher efficiency and a smaller footprint compared to conventional methods. FlotArt® induced gas flotation technology excels in removing free oil and fine solids from water, offering a multi-cell horizontal vessel design for optimal performance.
A key distinguishing feature is the vertically integrated approach, encompassing all manufacturing steps internally, from initial design through to plant realization and Factory Acceptance Testing (FAT). This comprehensive capability of managing the entire manufacturing process in-house ensures meticulous control and oversight at every stage of the process, resulting in superior quality and efficiency.
















